oxytocin vs oxytocin & methylergometrine in controlling intrapartum cesarean section

A Randomised Control Trial comparing effectiveness of oxytocin with methylergometrine with Oxytocin alone in patients undergoing intrapartum cesarean section - nil

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/07/055548

Enrollment

190

Registered

2023-07-24

Start date

Unknown

Completion date

Unknown

Last updated

2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Methylergometrine (0.2 mg IM )with oxytocin (5U iv ) in intervention group for 24 hrs post delivery: Methylergometrine ( intramuscularly 0.2 mg )with oxytocin (5 IU intravenously slow b

Eligibility

Inclusion criteria

Inclusion criteria: pregnant women 18 years and above laboring patients who undergo a cesarean section

Exclusion criteria

Exclusion criteria: placental / uterine abnormalities chronic HTN , Gestational HTN, Preeclampsia HIV/AIDS on protease inhibitors history of Coronary heart disease history of hypersensitivity to methylergometrine underlying uncorrected structural heart disease

Design outcomes

Primary

Measure	Time frame
To evaluate the effectiveness of multimodal prophylactic uterotonic x 24 hours post deliveryTimepoint: INTRAOPERATIVELY	—

Secondary

Measure	Time frame
blood loss estimation hb fall post cesarean uterine tone assessment patient requiring blood transfusionTimepoint: blood loss ( 2 hours ) hb fall post cesarean (24 hours) uterine tone assessment (4 mins ) patient requiring blood transfusion( till the day of discharge )	—

Countries

India

Contacts

Public ContactDr Aayushi Mahalle

AIIMS Jodhpur

longshanks28@gmail.com8003996917

Outcome results